| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 8.9e-05 | 1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 7e-05 | 1 |